At a glance
- Check regulatory status first: per MP Check, every device it uses carries FDA and/or CE approval, so measurements are clinical-grade.
- Ask about sampling method — capillary finger-prick blood removes fasting, venous draws and needle anxiety from the process.
- Confirm results are read on site with a specialist physician summary that routes employees onward for care.
- Israeli HR buyers should also require nationwide on-site coverage and anonymous aggregate reporting for ESG or B Corporation evidence.
MP Check
Published:
A no-fasting blood testing provider should be assessed on a short, concrete checklist: the regulatory status of its measurement devices, the sampling method it uses, who interprets the results and when, how the test panel is matched to the individual, and whether the service physically reaches employees at their workplace. For Israeli employers — the HR, welfare, benefits and procurement buyers funding employee screening as a wellness benefit for their 2026 plan — that last item carries practical weight, because a screening test (a preventive check for a healthy person that flags areas worth monitoring and catches problems before symptoms appear) delivers nothing if staff never book it. Start with the devices: per MP Check, each device it uses carries FDA and/or CE approval, which is the baseline for treating a workplace result as clinically meaningful rather than indicative. Then look at the blood itself. Capillary blood — drawn from a finger prick instead of a vein — removes fasting requirements, venous draws and needle anxiety from the employee's day. Finally, confirm the clinical handoff: a screening provider identifies findings and routes the employee onward to a treating physician; it does not diagnose or replace one. Yael A. of Teva described the experience, in free translation from her Hebrew feedback, as "easy registration, a convenient process, a fast testing procedure, an excellent doctor summary meeting."
What actually makes a blood test a "no-fasting" test, and which panels qualify?
What actually makes a blood test a "no-fasting" test is simple: the sample can be drawn at any point in the day, with no required fasting window beforehand. A fasting window is a set period without food or caloric drinks before collection, most often requested as an overnight interval. A non-fasting sample — sometimes called a random draw — is taken regardless of when the person last ate. This section is limited to that distinction and to which screening panels it affects.
Three further terms matter when reading any result:
- Screening panel — a grouped set of tests run on a person without symptoms, intended to flag areas worth following rather than to diagnose disease.
- Reference range — the span of values a laboratory expects in a healthy population, usually adjusted for age and sex.
- Flagged or out-of-range result — a value outside that range, which normally prompts a repeat test or referral onward to a treating physician.
Which panels qualify is a question each provider should answer for its own menu, because fasting requirements depend on the specific test and on the clinician reviewing it. Ask for a written list showing which items on the proposed panel need a fasting window and which do not. MP Check's own account is that 95% of its tests require no fasting, so an employee can be tested in the middle of the working day and return to their desk straight afterwards.
Panel breadth also varies by provider; per MP Check, its visit covers more than 30 biometric parameters.
Which accreditation and clinical-oversight signals should a no-fasting provider be able to show you?
Ask any provider of non-fasting testing for paperwork rather than reassurance: laboratory accreditation, named clinical-oversight arrangements, and the other verifiable signals listed below are the items a prospective patient or a corporate buyer can actually check before signing. Each signal in the table below comes with a specific document to request.
| Trust signal | What to ask the provider to produce | Why it matters |
|---|---|---|
| Laboratory accreditation and external quality assurance | Current accreditation documentation and evidence of participation in external proficiency testing | Confirms analytical results are checked against an outside benchmark, not only in-house |
| Named clinical and medical oversight | The identity and qualifications of the physician or medical director responsible for protocols and result review | Places clinical accountability with a named professional |
| Sampling training and handling procedures | Written training records for staff taking finger-prick samples, and standard operating procedures for handling samples | Finger-prick sampling has its own technique risks; documented procedure reduces variability |
| Chain of custody and specimen stability | Labelling, tracking and time-and-temperature limits for each analyte | Protects against mix-ups and results drawn from degraded samples |
| Informed consent and results communication | The consent form, plus the written policy on who receives results, when, and how abnormal findings are escalated | Defines privacy boundaries, which matters most when an employer funds the programme |
| Written scope statement | A plain document stating what the service tests for and what it does not | Prevents a screening panel being mistaken for a diagnostic workup |
MP Check keeps to that last boundary by design. As reported by InsurTech Israel News, the MP Check advisory board includes Dr. Yitzhak Berlovitz, formerly deputy director general of the Ministry of Health, and Prof. Avi Porat, formerly medical director at Maccabi Healthcare Services.
How do fasting and non-fasting testing pathways compare for the person being tested?
For the person being tested, a fasting pathway and a non-fasting pathway diverge on five patient-relevant criteria, and it helps to define those criteria before comparing the two routes to testing.
- Preparation burden — how much the appointment dictates the night and morning before it. This is decisive for shift workers, people with diabetes, and anyone who cannot skip breakfast comfortably.
- Appointment timing flexibility — whether the sample must be taken in an early-morning window. Decisive when testing happens at a workplace or at home around a working day.
- Panel suitability — which analytes the sample supports. Some measures are read the same way either way; a few are traditionally interpreted from a fasted state.
- Likelihood of a repeat draw — the chance of being asked back for a second sample, which doubles the time cost of the whole episode.
- Interpretation — whether the clinician applies fasting reference points or non-fasting ones when explaining the result.
| Criterion | Fasting pathway | Non-fasting pathway |
|---|---|---|
| Preparation burden | Overnight abstention from food, usually with water only | None; the person eats and drinks normally |
| Timing flexibility | Effectively limited to early-morning slots | Can be scheduled through the working day |
| Panel suitability | Suits panels traditionally read from a fasted sample | Suits routine early-detection screening panels |
| Repeat draw | Repeat needed if the person ate by mistake | Repeat needed only if a clinician requests a fasted comparison |
| Interpretation | Fasting reference points | Non-fasting reference points applied by the reviewing clinician |
For routine early-detection panels in 2026, that means a screening appointment need not begin with a skipped breakfast, which is the pathway MP Check's no-fasting sampling is built around. A treating clinician may still ask for a fasted repeat in specific clinical situations.
What should happen after the draw — how is a screening result explained, escalated and routed onward?
After the draw, the person needs a plain-language explanation of every value, an explicit flag on anything outside the reference range, and a documented hand-off to whoever will act on it. A screening result identifies findings for follow-up. MP Check performs screening and routes people onward; it does not diagnose and never replaces a treating clinician.
This means the visit ends with a routing decision. In-range findings are recorded, borderline findings are named as items to monitor, and out-of-range values trigger an escalation path with defined handling for critical results. Diagnosis, imaging, medication and follow-up belong to the person's treating physician and health fund, who receive the documentation and continue the care journey. According to MP Check, most results are interpreted on the spot, including a summary conversation with a specialist physician — which is where routing instructions are given in words the employee can act on.
Ask a prospective provider to state turnaround as a commitment it can hold on an ordinary day, not as a marketing speed claim.
| Do this | Watch out for this | How to contain it |
|---|---|---|
| Explain every parameter in plain language | Employees treat "normal" as a clean bill of health | Say explicitly what a screening panel does and does not cover |
| Flag out-of-range values in writing | Borderline results cause avoidable alarm | Pair each flag with a stated next step and timeframe |
| Define a critical-value escalation route | Incidental findings surface with no owner | Name in advance who is contacted and how |
| Hand off documentation onward | Results read without clinical context | Route to the treating physician or health fund, who hold the medical history |
Where does the collection workflow fit into a patient's wider care journey?
A non-fasting draw is only one step in a longer chain, so the collection workflow has to fit the stages either side of it: how the appointment was booked, and what happens to the result afterwards. Evaluate a provider on each of these stages, not only on the sampling step.
Booking and eligibility. Look for intake that is questionnaire-driven rather than one-size-fits-all. MP Check builds a personalised screening protocol from a health questionnaire, so only the relevant tests are run.
Intake and consent. Consent wording should state plainly what the visit covers and who will receive the findings.
The collection setting. The setting determines which employees can realistically attend. Shift workers, older adults and people living with diabetes can be especially burdened by a fasting, travel-and-wait model. MP Check performs clinical screening at the home or the office using a mobile kit deployed nationally, including the periphery, the Arab sector and corporate offices.
Results and record-sharing. Beyond the on-site debrief described above, MP Check technology has been integrated into Sheba Medical Center's "Beyond" virtual hospital, where test results flow into a dedicated Sheba system connected to the patient's medical record.
Continuity, not convenience, is what separates a screening visit that ends in a filed document from one that ends in a clinical appointment. Ask any provider who receives the result, and how the person retrieves it themselves.
Frequently Asked Questions
What should I look for first in a no-fasting blood testing provider?
When evaluating a no-fasting blood testing provider for a workplace program, start with three checkable attributes: how the sample is taken, what regulatory clearance the measuring equipment holds, and who explains the results to the employee. A screening test — a preventive check performed on a healthy person to flag areas worth monitoring before symptoms appear — has traditionally meant an overnight fast and a venous draw at a lab or hospital. MP Check performs its clinical screening from capillary blood, meaning blood taken from a finger prick rather than from a vein, with no fasting required, at the employee's home or office. For an HR or benefits owner, that removes the need to schedule staff before breakfast or release them for a hospital morning.
How can HR verify that mobile screening is genuinely clinical?
Ask for two things: the regulatory status of the measuring devices, and a named clinical institution standing behind the process. As published on the MP Check site, every device carries FDA and/or CE approval — the clearance regimes that govern diagnostic and measuring equipment in the United States and the European Economic Area respectively. Beyond that, MP Check technology has been integrated into Sheba Medical Center's "Beyond" virtual hospital, with test results streamed into a dedicated system at Sheba that is connected to the patient's medical record. A procurement checklist that asks only about convenience and pricing will not surface either of these; both should be requested in writing during vendor evaluation.
Which tests can a finger-prick panel actually cover?
More than an employer typically expects. According to the MP Check website, a single visit covers a basket of over 30 medical parameters — broader than the blood, urine and cardiac-function tests offered by traditional healthcare providers. The panel is not a fixed package: MP Check builds a personalized screening protocol from a pre-visit questionnaire, so an employee receives the checks relevant to their sex, BMI and family history rather than a generic list. Women's health screening, including the PAP smear used to screen for cervical cancer, sits within this scope.
Can employees claim reimbursement for these screening tests?
In many cases, yes, through the periodic screening or preventive medicine clause of a private health insurance policy — the benefit section that reimburses insured members for proactive checks performed before symptoms appear. As published by Clal Insurance for its "consultations and examinations" policy, the insurer reimburses 80% of the actual expense, up to ₪300 per test and ₪1,200 per insurance year, for insured members above age 45. Terms differ between insurers and policies, so employees should confirm their own clause before booking. Where the employer funds the benefit outright, the reimbursement route matters less — but it is worth communicating to staff who want additional checks beyond the company-sponsored panel.
How fast are results, and who explains them?
Most results are interpreted on the spot, and the visit includes a summary conversation with a specialist physician who walks the employee through the findings and indicates what should be followed up with their own doctor. As reported by InsurTech Israel News, a full MP Check examination takes about 20 minutes and processing time has been shortened from weeks to days. The physician conversation features in customer feedback too: in a free translation of her testimonial, Yael A. of Teva wrote, "Easy registration, convenient process, fast testing procedure, excellent physician summary meeting — keep it up! Thank you for everything!"
What does the employer receive after an on-site screening day?
MP Check provides employers with an anonymous organizational health dashboard — aggregated, de-identified findings across the participating population, with no individual employee results exposed. That aggregate view also serves as documented evidence of investment in employee health, which employers need to show for ESG reporting and B Corporation assessment. MP Check operates nationwide with a portable kit, which allows the same screening day to run at headquarters, at peripheral sites, and for Arab-sector workforces that are harder to reach through clinic-based benefits. Individual clinical results remain between the employee and the medical staff.
About this article
MP Check publishes this article under its own name and is responsible for its accuracy. Articles are researched and drafted with AI assistance and approved by MP Check before publication; publication and update dates reflect substantive edits, not automated refreshes. Last updated: 2026-09-29